• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机试验评估文拉法辛和大豆蛋白对前列腺癌男性热潮红及生活质量的影响。

Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.

机构信息

Mara Z. Vitolins, Leah Griffin, Bart Frizzel, Glenn J. Lesser, Michelle Naughton, and Edward G. Shaw, Wake Forest School of Medicine; Dawn Moose, Novant Health, Winston-Salem; James E. Radford Jr, Hendersonville Hematology/Oncology, Hendersonville, NC; W. Vic Tomlinson, AnMed Health, Anderson, SC; Jacqueline Vuky, Virginia Mason Medical Center, Seattle, WA; and Paul T. Adams, National Surgical Adjuvant Breast and Bowel Project, Genesys Regional Medical Center, Flint, MI.

出版信息

J Clin Oncol. 2013 Nov 10;31(32):4092-8. doi: 10.1200/JCO.2012.48.1432. Epub 2013 Sep 30.

DOI:10.1200/JCO.2012.48.1432
PMID:24081940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3816959/
Abstract

PURPOSE

Hot flashes occur in approximately 80% of androgen-deprived men. Few intervention studies have been conducted to relieve hot flashes in men.

PATIENTS AND METHODS

Eligible androgen-deprived men were randomly assigned to one of four daily regimens (2 × 2 factorial design) for 12 weeks: milk protein powder and placebo pill, venlafaxine and milk protein powder, soy protein powder and placebo pill, or venlafaxine and soy protein powder. The primary end point was hot flash symptom severity score (HFSSS), defined as number of hot flashes times severity. The secondary end point was quality of life (QoL), assessed by using the Functional Assessment of Cancer Therapy-Prostate.

RESULTS

In all, 120 men age 46 to 91 years participated. Most were white (78%) and overweight or obese (83%). Toxicity was minimal. Neither venlafaxine nor soy protein alone or in combination had a significant effect on HFSSS. Soy protein, but not venlafaxine, improved measures of QoL.

CONCLUSION

In androgen-deprived men, neither venlafaxine nor soy proved effective in reducing hot flashes. Interventions that appear effective for decreasing hot flashes in women may not always turn out to be effective in men.

摘要

目的

大约 80%的去雄激素男性会出现热潮红。针对缓解男性热潮红的干预研究较少。

患者和方法

符合条件的去雄激素男性被随机分配到四种每日方案(2×2 析因设计)中,持续 12 周:乳清蛋白粉和安慰剂丸、文拉法辛和乳清蛋白粉、大豆蛋白粉和安慰剂丸或文拉法辛和大豆蛋白粉。主要终点是热潮红症状严重程度评分(HFSSS),定义为热潮红次数乘以严重程度。次要终点是生活质量(QoL),采用癌症治疗前列腺功能评估量表进行评估。

结果

共有 120 名年龄在 46 至 91 岁的男性参与。大多数为白人(78%)和超重或肥胖(83%)。毒性极小。文拉法辛或大豆蛋白单独或联合使用均对 HFSSS 无显著影响。大豆蛋白而非文拉法辛改善了 QoL 测量指标。

结论

在去雄激素男性中,文拉法辛和大豆蛋白均不能有效减少热潮红。对女性减少热潮红有效的干预措施在男性中不一定有效。

相似文献

1
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.随机试验评估文拉法辛和大豆蛋白对前列腺癌男性热潮红及生活质量的影响。
J Clin Oncol. 2013 Nov 10;31(32):4092-8. doi: 10.1200/JCO.2012.48.1432. Epub 2013 Sep 30.
2
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.用于治疗因前列腺癌接受促性腺激素释放激素类似物治疗而出现血管舒缩性热潮红的男性患者的文拉法辛、醋酸甲羟孕酮和醋酸环丙孕酮的疗效:一项双盲、随机试验。
Lancet Oncol. 2010 Feb;11(2):147-54. doi: 10.1016/S1470-2045(09)70338-9. Epub 2009 Dec 4.
3
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.用文拉法辛和可乐定治疗患有乳腺癌的患者的热潮红:一项随机、双盲、安慰剂对照试验。
J Clin Oncol. 2011 Oct 10;29(29):3862-8. doi: 10.1200/JCO.2010.33.1298. Epub 2011 Sep 12.
4
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.文拉法辛用于治疗因前列腺癌接受雄激素剥夺治疗的男性潮热的初步评估。
J Urol. 1999 Jul;162(1):98-102. doi: 10.1097/00005392-199907000-00024.
5
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.文拉法辛用于乳腺癌后潮热的随机、双盲、安慰剂对照交叉试验。
Oncologist. 2007 Jan;12(1):124-35. doi: 10.1634/theoncologist.12-1-124.
6
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.在伴有热潮红的乳腺癌患者中,用唑吡坦增强文拉法辛和选择性 5-羟色胺再摄取抑制剂可改善睡眠和生活质量:一项随机、双盲、安慰剂对照试验。
Menopause. 2010 Sep-Oct;17(5):908-16. doi: 10.1097/gme.0b013e3181dbee1b.
7
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.文拉法辛在治疗乳腺癌患者潮热方面优于可乐定——一项双盲、随机研究。
Ann Oncol. 2007 Apr;18(4):689-93. doi: 10.1093/annonc/mdl478. Epub 2007 Jan 17.
8
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.醋酸甲羟孕酮与文拉法辛治疗潮热的III期比较:北中部癌症治疗组试验N99C7
J Clin Oncol. 2006 Mar 20;24(9):1409-14. doi: 10.1200/JCO.2005.04.7324. Epub 2006 Feb 27.
9
Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.文拉法辛用于控制潮热:一项纵向延续性研究的结果
Oncol Nurs Forum. 2002 Jan-Feb;29(1):33-40. doi: 10.1188/02.ONF.33-40.
10
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.盐酸文拉法辛治疗癌症幸存者潮热的初步评估。
J Clin Oncol. 1998 Jul;16(7):2377-81. doi: 10.1200/JCO.1998.16.7.2377.

引用本文的文献

1
[Integration of complementary medicine in uro-oncology].[辅助医学在泌尿肿瘤学中的整合]
Urologie. 2025 Sep;64(9):925-932. doi: 10.1007/s00120-025-02639-w. Epub 2025 Jul 15.
2
Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.雄激素剥夺疗法治疗前列腺癌:关注认知功能和情绪。
Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077.
3
A hospital-based therapeutic food pantry study for people living with cancer in New Orleans.新奥尔良市面向癌症患者的医院治疗性食品储藏室研究。
Support Care Cancer. 2023 Nov 20;31(12):712. doi: 10.1007/s00520-023-08171-x.
4
Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial.针刺与假针刺和常规护理治疗前列腺癌雄激素诱导热潮红(AVAIL):一项随机临床试验研究方案。
BMC Complement Med Ther. 2023 Oct 27;23(1):388. doi: 10.1186/s12906-023-04218-y.
5
A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2).一项针对接受雄激素剥夺治疗的前列腺癌患者管理热潮红和盗汗影响的引导自助认知行为疗法的多中心随机对照试验(MANCAN2)。
Trials. 2023 Jul 10;24(1):450. doi: 10.1186/s13063-023-07325-w.
6
Antidepressants for the treatment of depression in people with cancer.抗抑郁药治疗癌症患者的抑郁症。
Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD011006. doi: 10.1002/14651858.CD011006.pub4.
7
Comparing Interventions for Management of Hot Flashes in Patients With Breast and Prostate Cancer: A Systematic Review With Meta-Analyses.比较乳腺癌和前列腺癌患者热潮红管理干预措施的系统评价和荟萃分析。
Oncol Nurs Forum. 2020 Jul 1;47(4):E86-E106. doi: 10.1188/20.ONF.E86-E106.
8
The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: a systematic review.生活方式干预对减少前列腺癌男性雄激素剥夺治疗副作用的有效性:系统评价。
Qual Life Res. 2020 Apr;29(4):843-865. doi: 10.1007/s11136-019-02361-z. Epub 2019 Dec 12.
9
Diet and lifestyle considerations for patients with prostate cancer.前列腺癌患者的饮食和生活方式注意事项。
Urol Oncol. 2020 Mar;38(3):105-117. doi: 10.1016/j.urolonc.2019.06.018. Epub 2019 Jul 18.
10
Antidepressants for the treatment of depression in people with cancer.用于治疗癌症患者抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2018 Apr 23;4(4):CD011006. doi: 10.1002/14651858.CD011006.pub3.

本文引用的文献

1
Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis.大豆异黄酮与安慰剂治疗更年期血管舒缩症状的比较:系统评价和荟萃分析。
Menopause. 2010 May-Jun;17(3):660-6.
2
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.用于治疗因前列腺癌接受促性腺激素释放激素类似物治疗而出现血管舒缩性热潮红的男性患者的文拉法辛、醋酸甲羟孕酮和醋酸环丙孕酮的疗效:一项双盲、随机试验。
Lancet Oncol. 2010 Feb;11(2):147-54. doi: 10.1016/S1470-2045(09)70338-9. Epub 2009 Dec 4.
3
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy.高剂量异黄酮对接受雄激素剥夺治疗的前列腺癌男性患者无疗效。
J Urol. 2009 Nov;182(5):2265-72. doi: 10.1016/j.juro.2009.07.030. Epub 2009 Sep 16.
4
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.文拉法辛与可乐定治疗乳腺癌患者潮热的双盲随机交叉研究。
Breast Cancer Res Treat. 2009 Jun;115(3):573-80. doi: 10.1007/s10549-008-0138-7. Epub 2008 Aug 1.
5
Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.金雀异黄素对帕金森病小鼠模型中多巴胺能神经元的神经保护作用。
Neurosci Res. 2008 Feb;60(2):156-61. doi: 10.1016/j.neures.2007.10.005. Epub 2007 Oct 23.
6
Phytoestrogens for vasomotor menopausal symptoms.植物雌激素用于治疗更年期血管舒缩症状。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD001395. doi: 10.1002/14651858.CD001395.pub3.
7
Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency.豆制品和大豆异黄酮补充剂缓解更年期症状的功效与初始潮热频率呈正相关。
J Med Food. 2003 Spring;6(1):1-11. doi: 10.1089/109662003765184697.
8
Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study.大豆蛋白和异黄酮对围绝经期及绝经后女性血管舒缩症状的影响:大豆雌激素替代研究
Menopause. 2003 Mar-Apr;10(2):147-53. doi: 10.1097/00042192-200310020-00006.
9
Pathophysiology and treatment of hot flashes.潮热的病理生理学与治疗
Mayo Clin Proc. 2002 Nov;77(11):1207-18. doi: 10.4065/77.11.1207.
10
Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.大豆植物雌激素对绝经后乳腺癌女性潮热的影响:一项随机对照临床试验。
J Clin Oncol. 2002 Mar 15;20(6):1449-55. doi: 10.1200/JCO.2002.20.6.1449.